Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C21H24F3N |
| Molecular Weight | 347.4172 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1C2=CC=CC=C2[C@H](CCCN(C)C)C3=CC(=CC=C13)C(F)(F)F
InChI
InChIKey=JTAJFHGSVCEPKC-KUHUBIRLSA-N
InChI=1S/C21H24F3N/c1-14-16-7-4-5-8-18(16)19(9-6-12-25(2)3)20-13-15(21(22,23)24)10-11-17(14)20/h4-5,7-8,10-11,13-14,19H,6,9,12H2,1-3H3/t14-,19+/m1/s1
| Molecular Formula | C21H24F3N |
| Molecular Weight | 347.4172 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9804284
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9804284
Fluotracen (SKF-28,175) is a tricyclic drug which possesses dual antidepressant and antipsychotic activity mediated through blockage of GABA(A) receptors.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Fluotracen (SKF 28, 175): a new antidepressant. Double-blind study with amitriptyline. | 1980 |
|
| Clinical experience with fluotracen HCL: report of a case. | 1979 |
|
| Fluotracen: a tricyclic compound with the combined properties of antidepressants and antipsychotics in animals. | 1977 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:41:21 GMT 2025
by
admin
on
Mon Mar 31 18:41:21 GMT 2025
|
| Record UNII |
3026WKR55S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C166611
Created by
admin on Mon Mar 31 18:41:21 GMT 2025 , Edited by admin on Mon Mar 31 18:41:21 GMT 2025
|
PRIMARY | |||
|
Fluotracen
Created by
admin on Mon Mar 31 18:41:21 GMT 2025 , Edited by admin on Mon Mar 31 18:41:21 GMT 2025
|
PRIMARY | |||
|
100000080716
Created by
admin on Mon Mar 31 18:41:21 GMT 2025 , Edited by admin on Mon Mar 31 18:41:21 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110950
Created by
admin on Mon Mar 31 18:41:21 GMT 2025 , Edited by admin on Mon Mar 31 18:41:21 GMT 2025
|
PRIMARY | |||
|
SUB07722MIG
Created by
admin on Mon Mar 31 18:41:21 GMT 2025 , Edited by admin on Mon Mar 31 18:41:21 GMT 2025
|
PRIMARY | |||
|
DTXSID101043327
Created by
admin on Mon Mar 31 18:41:21 GMT 2025 , Edited by admin on Mon Mar 31 18:41:21 GMT 2025
|
PRIMARY | |||
|
35764-73-9
Created by
admin on Mon Mar 31 18:41:21 GMT 2025 , Edited by admin on Mon Mar 31 18:41:21 GMT 2025
|
PRIMARY | |||
|
3026WKR55S
Created by
admin on Mon Mar 31 18:41:21 GMT 2025 , Edited by admin on Mon Mar 31 18:41:21 GMT 2025
|
PRIMARY | |||
|
76957024
Created by
admin on Mon Mar 31 18:41:21 GMT 2025 , Edited by admin on Mon Mar 31 18:41:21 GMT 2025
|
PRIMARY | |||
|
C015220
Created by
admin on Mon Mar 31 18:41:21 GMT 2025 , Edited by admin on Mon Mar 31 18:41:21 GMT 2025
|
PRIMARY | |||
|
4228
Created by
admin on Mon Mar 31 18:41:21 GMT 2025 , Edited by admin on Mon Mar 31 18:41:21 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |